Diba names new general manager

Mick Pearson takes responsibility for the Cambridge, UK fluid handling component plant

To streamline operations at its Cambridge, UK plant and promote communication with its US headquarters, Diba Industries has named Mick Pearson as general manager.

Pearson will be responsible for the day-to-day operations at the fluid handling component manufacturing plant. He was previously business operations manager at Weetabix (Northamptonshire, UK) and site manager at Nampak Plastics Europe (Buckinghamshire, UK).

Diba, part of the multinational Halma technology group, provides custom engineered fluid handling components and design services. The company is headquartered in Danbury, Connecticut, US with global locations in the UK, China, and Japan.

You may also like

Manufacturing

Omnifit bottle cap traps harmful vapours

Integrated test strip indicates when to replace cap
Manufacturing

Bracco enters cell therapy manufacturing with microbubble-based cell selection technology

Bracco Imaging is expanding into cell therapy manufacturing with a bead-free cell selection and activation technology based on its clinically validated microbubble platform
Manufacturing

New manufacturing line from Adragos granted regulatory approval from Swissmedic

The approval of the new, state-of-the-art facility follows a comprehensive modernisation programme in 2024/2025 that has focussed on ensuring the future-readiness of the plant
Manufacturing

Freudenberg Medical launches new hydrophilic coating LUBRITEQ

The launch comes alongside a comprehensive suite of associated development and manufacturing services designed to remove commercial barriers and enable long-term, trust-based partnerships
Manufacturing

The REACTEX range - cutting-edge components, unmatched precision

Utilising cutting-edge components from leading UK and German manufacturers, the REACTEX range of interchangeable glass reactors offer the following:
Manufacturing

Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies

Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
Manufacturing

Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan

The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031
Subscribe now